logo
logo

Btr Raises $15 Million In Series A Round To Transform The Validation Process For Life Sciences Companies

Feb 09, 2022•over 3 years ago

Amount Raised

$15 Million

Round Type

series a

Boston

Description

BTR (Boston Technology Research), a regulatory technology company serving healthcare, life sciences and SaMD, today announced that is has raised $15 million in a Series A round led by New York-based global venture capital and private equity firm Insight Partners, with participation from LRV Health, NewStack Ventures and other investors. The new funding will be used to ensure that customers are prepared for the FDA’s anticipated guidance that will incentivize a move from traditional methods to new technologies.

Company Information

Company

Btr

Location

Boston, Massachusetts, United States

About

BTR is a regulatory technology company serving healthcare, life sciences and SaMD. It has been the compliance engine behind leading software vendors such as Veeva, Nuvolo and Benchling, and has helped more than 275 healthcare and life sciences companies transition to the regulated cloud. BTR’s enterprise-wide compliance platform is used across leading software vendors and sponsors alike, including customers, like Glaukos, Dermavant, Lexicon and Atsena. BTR is headquartered in Chelsea, MA, with a global workforce located throughout North America, Europe and Asia. To learn more about the company’s seamless validation solutions including a demo, please visit BostonTR.com, email the team at info@bostontr.com or follow us on LinkedIn.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech